Development of a Wearable Device for Osteoporosis Prevention and Fracture Risk Reduction in Women
Launched by UNIVERSITY OF SEVILLE · Dec 15, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
CURRENT STATUS AND JUSTIFICATION OF THE PROPOSAL Osteoporosis is an important public health problem and it is characterized by the deterioration of the microarchitecture of bone tissue and a low bone mineral density (BMD) that leads to a reduction in bone strength and the consequent increased risk of skeletal fractures 1. One in three women will suffer an osteoporotic fracture in their lifetime 2. In fact, it is estimated that more than 200 million people suffer from osteoporosis and these figures are increasing due to the aging of the population and the change in lifestyles 3. A recent sys...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Postmenopausal women older than 40 years with ≤ 10 years after menopause ("early postmenopausal women").
- • Sedentary women (defined as not performing regular physical activity greater than 150 min of moderate-vigorous physical activity per week in the last six months).
- • Willing to give consent to participate in the study.
- Exclusion Criteria:
- • Surgically induced menopause or cancer treatment.
- • Low BMI (\<18 kg / m2).
- • Excessive alcohol consumption (≥3 drinks per day).
- • Smoker
- • Unstable cardiovascular disease.
- • Rheumatoid arthritis.
- • Chronic kidney disease
- • Diagnosis of conditions that alter bone metabolism (hypo/hypercalcemia, hyperthyroidism, hypo/hypergonadism).
- • Upper or lower limb fracture in the last 6 months.
- • Mobility problems or requiring assistance to walk.
- • Participation in physical exercise programs in the 6 months prior to the study.
- • Regular use of glucocorticoids or hormone replacement therapy in the past 3 months.
- • Unwillingness to complete the study requirements.
About University Of Seville
The University of Seville is a prestigious academic institution dedicated to advancing knowledge through innovative research and exceptional education. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials aimed at enhancing patient care and medical outcomes. Its commitment to rigorous scientific inquiry and ethical standards positions it as a leading sponsor in the field of clinical research, fostering partnerships with healthcare professionals and institutions to drive advancements in medical science and improve public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seville, , Spain
Patients applied
Trial Officials
Borja Sañudo, PhD
Principal Investigator
University of Seville
Sergio Tejero, PhD
Principal Investigator
Hospitales Universitarios Virgen del Rocío
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported